| Health: Cardiovascular Disease
Cardiovascular disease kills nearly a half a million women every year.Detecting the disease isn't always easy because the warning signs for women aren't always recognized.Heart Disease, millions of Americans face it, and many don't know they have it until they suffer an attack.Most heart attacks start slowly with mild pain or discomfort. At the onset of Lydia's attack, she had shortness of breath and new to get help. But for many women their symptoms aren't so typical."Their symptom complex is different. It's different than the classic training we all received as medical student," said Cardiologist Matthew DeCaro. Cardiologist Matthew DeCaro at Thomas Jefferson University Hospital says symptoms in women can be different from what men feel.Classic symptoms to look for include;- Chest pain or heavy pressure in your chest- Arm numbness- And shortness of breath.Some of the less recognized symptoms that women often experience;- Indigestion- Nausea- Fatigue- And dizziness."If you're having symptoms that you think are potentially heart related you shouldn't wait at all.
Customer Service
LONDON (AP) - AstraZeneca PLC announced it will slash 3,000 jobs over the next three years despite reporting its third successive year of earnings growth Thursday, stressing that it still needs to improve its weak pipeline of future drugs. The drug maker, which is facing patent challenges and escalating generic competition, revealed the job cuts as part of a US$500 million (euro384.02 million) three-year revamp of its supply chain as it said that sales growth would continue at a slower pace this year. Net profit for the three months to Dec. 31 rose 17 per cent to US$1.4 billion (euro1.08 billion), from US$1.2 billion a year earlier, AstraZeneca said. Revenue rose 14 per cent to US$7.2 billion (euro5.56 billion). For the full year, profits rose 28.5 per cent to US$6.04 billion (euro4.66 billion), while revenue lifted 11 per cent to US$26.8 billion (euro20.69 billion), marking the third year of growth since the expiration of a number of key patents in 2003.
Aspirin trial to test effect on cancer
DOCTORS and volunteers are being recruited to test the aspirin as a means of preventing one of Scotland's most lethal cancers. The humble painkiller is being used with an anti-ulcer drug to try to prevent Barrett's oesophagus from developing into cancer of the oesophagus, or gullet. Barrett's oesophagus is responsible for around half of all oesophageal cancers. Patients with the condition have stomach acid that rises into the oesophagus, usually causing heartburn. The acid damages the cells in the lining of the oesophagus and in some cases they turn cancerous. .
|
